Senseonics Holdings (SENS) Capital Expenditures Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -74.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.42% |
| Dec 31, 2025 | 62.62% |
| Sep 30, 2025 | 429.06% |
| Jun 30, 2025 | -118.16% |
| Mar 31, 2025 | 37.34% |
| Dec 31, 2024 | -25,428.57% |
| Sep 30, 2024 | -265.04% |
| Jun 30, 2024 | 23,144.44% |
| Mar 31, 2024 | 558.33% |
| Dec 31, 2023 | -112.28% |
| Sep 30, 2023 | 179.55% |
| Jun 30, 2023 | -87.84% |
| Mar 31, 2023 | -64.96% |
| Dec 31, 2022 | 226.67% |
| Sep 30, 2022 | 57.14% |
| Jun 30, 2022 | 105.56% |
| Mar 31, 2022 | 1,145.45% |
| Sep 30, 2021 | -82.61% |
| Jun 30, 2021 | 228.57% |
| Mar 31, 2021 | -77.08% |
| Sep 30, 2020 | -79.39% |
| Jun 30, 2020 | 87.39% |
| Mar 31, 2020 | -87.76% |
| Dec 31, 2019 | -81.98% |
| Sep 30, 2019 | 54.04% |
| Jun 30, 2019 | -236.20% |
| Mar 31, 2019 | 2,915.38% |
| Dec 31, 2018 | -1,152.08% |
| Sep 30, 2018 | 401.98% |
| Jun 30, 2018 | -2.98% |
| Mar 31, 2018 | -53.57% |
| Dec 31, 2017 | 77.78% |
| Sep 30, 2017 | 12.22% |
| Jun 30, 2017 | -48.31% |
| Mar 31, 2017 | -24.32% |
| Sep 30, 2016 | -26.83% |
| Jun 30, 2016 | 432.79% |